Jounce Therapeutics News

JNCEDelisted Stock  USD 1.88  0.00  0.00%   
About 56% of Jounce Therapeutics' investor base is looking to short. The analysis of current outlook of investing in Jounce Therapeutics suggests that many traders are alarmed regarding Jounce Therapeutics' prospects. The current market sentiment, together with Jounce Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Jounce Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
over a year ago at globenewswire.com         
Termination of Proposed Business Combination of Jounce Therapeutics, Inc. and Redx Pharma plc
Macroaxis News: globenewswire.com
over a year ago at news.google.com         
Termination of Proposed Business Combination of Jounce ... - GlobeNewswire
Google News at Macroaxis
over a year ago at simplywall.st         
Jounce Therapeutics shareholders are up 23 percent this past week, but still in the red over the las...
Simply Wall St News at Macroaxis
over a year ago at news.google.com         
Millennium Partners, L.P. UK Regulatory Announcement Form 8.3 ... - ACROFAN USA
Google News at Macroaxis
over a year ago at news.google.com         
Millennium Partners, L.P. UK Regulatory Announcement Form 8.3 ... - ACROFAN USA
Google News at Macroaxis
over a year ago at zacks.com         
Jounce Up 21 percent on Accepting Concentras Buyout Offer
zacks News
over a year ago at finance.yahoo.com         
6 analyst cuts of the day Marathon stock lowered at JPMorgan Pro Recap
Yahoo News
over a year ago at kalkinemedia.com         
Jounce dumps Redx Pharma for acquisition by Concentra to cut 84 percent of jobs
news
over a year ago at bizjournals.com         
Jounce pivots, agrees to 96.5M acquisition by mysterious biotech
bizjournals News
over a year ago at businesswire.com         
JNCE STOCK ALERT Halper Sadeh LLC Is Investigating Whether the Sale of Jounce Therapeutics, Inc. Is ...
businesswire News
over a year ago at businesswire.com         
JNCE STOCK ALERT Halper Sadeh LLC Is Investigating Whether the Sale of Jounce Therapeutics, Inc. Is ...
businesswire News
over a year ago at marketwatch.com         
Jounce Therapeutics Shares Rally on Buyout Deal JNCE
marketwatch News
over a year ago at reuters.com         
Jounce dumps Redx Pharma for acquisition by Concentra to cut 84 percent of jobs
reuters
over a year ago at finance.yahoo.com         
Jounce dumps Redx Pharma for acquisition by Concentra to cut 84 percent of jobs
Yahoo News
over a year ago at globenewswire.com         
Jounce Therapeutics Enters Into Agreement to Be Acquired by Concentra Biosciences for 1.85 in Cash p...
Macroaxis News: globenewswire.com
Far too much social signal, news, headlines, and media speculation about Jounce Therapeutics that are available to investors today. That information is available publicly through Jounce media outlets and privately through word of mouth or via Jounce internal channels. However, regardless of the origin, that massive amount of Jounce data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Jounce Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Jounce Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Jounce Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Jounce Therapeutics alpha.

Jounce Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Stocks to Watch eBay, Etsy, Jounce Therapeutics, Dutch Bros, Cheesecake Factory
02/22/2023
2
Jounce Therapeutics Inc expected to post a loss of9cents a share - Earnings Preview
02/24/2023
3
Why Is Boxed Stock Down 41 percent Today
03/15/2023
4
JNCE STOCK ALERT Halper Sadeh LLC Is Investigating Whether the Sale of Jounce Therapeutics, Inc. Is Fair to Shareholders
03/27/2023
5
Jounce Up 21 percent on Accepting Concentras Buyout Offer
03/28/2023
6
Millennium Partners, L.P. UK Regulatory Announcement Form 8.3 ... - ACROFAN USA
03/30/2023
7
Termination of Proposed Business Combination of Jounce Therapeutics, Inc. and Redx Pharma plc
04/03/2023
8
Jounce Therapeutics, Inc. Short Interest Down 11.4 percent in April
05/01/2023
9
Jounce Therapeutics Announces Closing of Tender Offer
05/04/2023
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Jounce Stock

If you are still planning to invest in Jounce Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Jounce Therapeutics' history and understand the potential risks before investing.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account